Related Experiment Videos
Resistance factors: influence on netilmicin activity
Scandinavian Journal of Infectious Diseases. Supplementum
|January 1, 1980
Summary
Netilmicin effectively combats bacterial resistance mediated by phosphorylation or adenylation enzymes. However, its activity varies against strains with acetylating enzymes and is ineffective against those with reduced permeability.
Area of Science:
- Microbiology
- Pharmacology
- Bacterial Resistance
Background:
- Aminoglycosides are crucial antibiotics, but bacterial resistance is a growing concern.
- Resistance mechanisms include enzymatic modification (phosphorylation, adenylation, acetylation) and reduced permeability.
- Netilmicin is a semi-synthetic aminoglycoside developed to overcome some resistance mechanisms.
Purpose of the Study:
- To evaluate the activity of netilmicin against bacterial strains with characterized aminoglycoside resistance mechanisms.
- To understand the specific enzymatic modifications that confer resistance or susceptibility to netilmicin.
Main Methods:
- In vitro susceptibility testing of netilmicin against a panel of bacterial strains.
- Characterization of aminoglycoside-modifying enzymes (phosphorylating, adenylating, acetylating) produced by resistant strains.
- Analysis of netilmicin's structural features in relation to its activity against specific enzyme types.
Main Results:
- Netilmicin demonstrates activity against strains producing phosphorylating or adenylating enzymes (e.g., ANT(2")).
- Activity is variable against strains producing AAC(3) enzymes, and netilmicin is inactive against strains producing AAC(2").
- Netilmicin is ineffective against bacteria resistant due to reduced cell wall permeability.
Conclusions:
- Netilmicin overcomes certain aminoglycoside resistance mechanisms, particularly those involving phosphorylation and adenylation.
- Its efficacy is limited by specific acetylation patterns and reduced bacterial permeability.
- Netilmicin remains a valuable option against a subset of aminoglycoside-resistant bacterial infections.